📣 VC round data is live. Check it out!

Public Comps and Valuation Multiples for Laboratory Services

Benchmark revenue and EBITDA valuation multiples for public comps like
Thermo Fisher Scientific, Danaher, Wuxi AppTec, IDEXX Laboratories and Waters.

Select Vertical

Laboratory Services

Viewing 50 of 75 companies with full data

Company	Market Cap	Enterprise Value	LTM Revenue	EV/LTM Revenue	EV/LTM EBITDA
Thermo Fisher Scientific	$171B	$211B	$46B	4.6x	18.3x
Danaher	$118B	$130B	$25B	5.2x	16.6x
Wuxi AppTec	$49B	$44B	$7B	6.2x	12.6x
IDEXX Laboratories	$42B	$43B	$4B	9.7x	27.4x
Waters	$35B	$39B	$4B	9.0x	26.6x
Agilent	$32B	$34B	$7B	4.7x	16.1x
Mettler Toledo	$22B	$24B	$4B	5.8x	18.6x
Labcorp	$21B	$27B	$14B	1.9x	11.2x
Quest Diagnostics	$21B	$27B	$11B	2.4x	12.1x
Sartorius	$19B	$21B	$4B	5.9x	19.2x
Eurofins Scientific	$12B	$16B	$9B	1.9x	8.3x
Revvity	$11B	$14B	$3B	4.8x	15.7x
Max Healthcare Institute	$10B	$11B	$1B	9.8x	38.5x
bioMérieux	$10B	$10B	$5B	2.0x	8.3x
Bangkok Dusit Medical Services	$9B	$9B	$4B	2.6x	10.8x
Charles River	$8B	$11B	$4B	2.8x	11.3x
ALS	$8B	$9B	$2B	3.7x	14.8x
Fortis Healthcare	$8B	$8B	$975M	8.0x	34.6x
Bio-Techne	$7B	$8B	$1B	6.2x	17.5x
Qiagen	$7B	$8B	$2B	3.8x	10.3x
Pharmaron Beijing	$7B	$7B	$2B	3.4x	14.4x
Sonic Healthcare	$7B	$11B	$8B	1.4x	7.9x
Repligen	$6B	$6B	$769M	8.2x	42.0x
Hangzhou Tigermed	$6B	$6B	$1B	5.9x	35.0x
Snibe	$6B	$5B	$700M	7.7x	17.5x
Avantor	$6B	$9B	$7B	1.4x	8.8x
Sotera Health	$4B	$6B	$1B	5.4x	10.5x
Genscript Biotech	$4B	$3B	$906M	3.9x	21.2x
Diasorin	$4B	$5B	$1B	3.3x	10.1x
MGI Tech	$3B	$3B	$430M	6.6x	90.3x
Dr. Lal PathLabs	$3B	$3B	$295M	9.0x	31.7x
BGI Genomics	$3B	$2B	$553M	4.0x	47.5x
Tecan Group	$2B	$2B	$1B	1.9x	12.2x
Neogen	$2B	$3B	$859M	2.9x	14.3x
Dian Diagnostics Group	$2B	$2B	$1B	1.3x	13.3x
Fleury	$2B	$2B	$2B	1.5x	5.8x
Haier Biomedical	$2B	$1B	$352M	3.9x	25.0x
Daan Gene	$1B	$1B	—	—	—
Guangzhou Wondfo Biotech	$1B	$1B	$333M	3.4x	20.3x
NeoGenomics	$1B	$1B	$754M	1.9x	29.2x
Clinica Baviera	$1B	$1B	$364M	3.0x	10.5x
BioLife Solutions	$1B	$971M	$103M	9.5x	36.4x
Novogene	$952M	$723M	$337M	2.1x	14.2x
Azenta	$808M	$484M	$598M	0.8x	7.7x
Jiangsu Bioperfectus	$803M	$631M	—	—	—
Diagnósticos da América	$785M	$2B	$2B	1.0x	5.1x
Assure Tech	$701M	$443M	—	—	—
Maravai LifeSciences	$687M	$792M	$195M	4.1x	(91.8x)
Integral Diagnostics	$592M	$1B	$557M	1.8x	8.8x
Indisa	$461M	$553M	—	—	—
Fulgent Genetics	$449M		$333M
Myriad Genetics	$384M		$839M
908 Devices	$289M		$61M
Eurobio Scientific	$278M		$201M
Australian Clinical Labs	$260M		$526M
Healius	$255M		$993M
Frontage Laboratories	$238M		$266M
OraSure	$204M		$117M
Bioneer	$167M		—
Suraksha Diagnostics	$159M		$32M
Biodesix	$159M		$97M
BICO Group	$136M		$170M
Atlantic International	$127M		$436M
Rapid Micro Biosystems	$118M		$36M
Fonet	$115M		—
CEL	$104M		$127M
Exagen	$89M		$68M
Novacyt	$77M		$30M
BATM Advanced Communications	$65M		$113M
Anatolia Geneworks	$64M		—
Gentian Diagnostics	$64M		$20M
Daxor	$61M		$9M
Co-Diagnostics	$6M		$622K
IMD Companies	$3M		—
Euroinvestment	$2M		—